Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Woodhams SG et al. |
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. |
2012 |
Br. J. Pharmacol. |
pmid:22924700
|
Hillard CJ et al. |
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. |
2007 |
Br. J. Pharmacol. |
pmid:17891162
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Rimmerman N et al. |
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. |
2008 |
Br. J. Pharmacol. |
pmid:17965731
|
Hohmann AG |
Inhibitors of monoacylglycerol lipase as novel analgesics. |
2007 |
Br. J. Pharmacol. |
pmid:17293886
|
Howlett AC et al. |
Endocannabinoid tone versus constitutive activity of cannabinoid receptors. |
2011 |
Br. J. Pharmacol. |
pmid:21545414
|
Booker L et al. |
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. |
2012 |
Br. J. Pharmacol. |
pmid:21506952
|
Liao HT et al. |
Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition. |
2011 |
Br. J. Pharmacol. |
pmid:21232043
|
De Petrocellis L et al. |
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. |
2011 |
Br. J. Pharmacol. |
pmid:21175579
|
Guindon J et al. |
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. |
2011 |
Br. J. Pharmacol. |
pmid:21198549
|
Petrosino S et al. |
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. |
2016 |
Br. J. Pharmacol. |
pmid:25598150
|
Izzo AA et al. |
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. |
2009 |
Br. J. Pharmacol. |
pmid:19371345
|
Ho WS et al. |
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. |
2015 |
Br. J. Pharmacol. |
pmid:26294342
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Mulder J et al. |
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. |
2011 |
Brain |
pmid:21459826
|
Doenni VM et al. |
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. |
2016 |
Brain Behav. Immun. |
pmid:27453335
|
Mecha M et al. |
Endocannabinoids drive the acquisition of an alternative phenotype in microglia. |
2015 |
Brain Behav. Immun. |
pmid:26086345
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Parker KE et al. |
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat. |
2015 |
Brain Res. |
pmid:26100333
|